MAVUPHARMA

mavupharma-logo

Mavupharma is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.

#People #Financial #Website #More

MAVUPHARMA

Industry:
Biotechnology Health Care Life Science Pharmaceutical

Founded:
2016-01-01

Address:
Kirkland, Washington, United States

Country:
United States

Website Url:
http://www.mavupharma.com

Total Employee:
1+

Status:
Closed

Email Addresses:
[email protected]

Total Funding:
20 M USD

Technology used in webpage:
SPF Font Awesome Apache Microsoft Exchange Online Office 365 Mail Linode



Current Advisors List

james-bristol_image

James Bristol Scientific Advisory Board @ Mavupharma
Advisor

james-topper_image

James Topper Board of Directors @ Mavupharma
Board_member

robert-baltera_image

Robert Baltera Director @ Mavupharma
Board_member

Current Employees Featured

not_available_image

Clayton D. Knox
Clayton D. Knox COO @ Mavupharma
COO

Founder


michael-gallatin_image

Michael Gallatin

Investors List

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series A - Mavupharma

alpine-bioventures_image

Alpine BioVentures

Alpine BioVentures investment in Series A - Mavupharma

Official Site Inspections

http://www.mavupharma.com

  • Host name: a44fc39dcd01d2028.awsglobalaccelerator.com
  • IP address: 99.83.176.46
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Mavupharma" on Search Engine